This is a preprint.
Impact of Differentiated Service Delivery Models on Quality of Life among People living with HIV in Uganda - A Quasi-Experimental Study
- PMID: 39764111
- PMCID: PMC11702836
- DOI: 10.21203/rs.3.rs-5443965/v1
Impact of Differentiated Service Delivery Models on Quality of Life among People living with HIV in Uganda - A Quasi-Experimental Study
Update in
-
Impact of differentiated service delivery models on quality of life among people living with HIV in Uganda- a quasi-experimental study.AIDS Res Ther. 2025 Jun 2;22(1):56. doi: 10.1186/s12981-025-00741-9. AIDS Res Ther. 2025. PMID: 40457424 Free PMC article.
Abstract
Background: Differentiated service delivery (DSD) models in resource-limited settings have reduced strain on health services and improved client experience, retention and viral suppression, but little is known about the impact of HIV DSD models on quality of life (QoL), which is essential for optimizing person-centered care. This study assessed the impact of DSD models on QoL, loss to follow-up (LTFU), and mortality among persons living with HIV (PLHIV) on ART over time at a large urban HIV clinic in Uganda.
Methods: We analyzed records of 1,000 PLHIV who had been on ART for 10 years and followed up for eight years, starting in 2014 or 2015 at the Infectious Diseases Institute clinic in Kampala, Uganda. The primary outcome, QoL, was assessed using an adapted Medical Outcomes Study (MOS-HIV) tool. Secondary outcomes included sustained viral suppression (< 200 copies/mL), all-cause mortality, and loss to follow-up or LTFU (missing clinic visits for ≥ 3 months). Outcomes were compared across three DSD models-fast-track drug refill (FTDR), facility-based groups (FBG), and a composite model combining FTDR and FBG against the facility-based individual management (FBIM), the standard of care (SOC). Inverse probability treatment weighting was used to achieve comparability in measured covariates across the DSD models followed by mixed effects modeling. Robustness of results was checked using G-computation analysis.
Results: Of 1,000 records for PLHIV, 980 were analyzed. 62% were female and 95% virally suppressed at baseline. After eight years of follow-up, participants on DSD models had higher QoL (90.4% vs 89.1%; weighted mean ratio 3.66, 95% CI 2.10-6.37, p-value < 0.001), better sustained viral suppression, lower mortality, and reduced LTFU rates compared to SOC.
Conclusion: These findings support the broader adoption of DSD models in delivering ART across HIV programs to enhance the QoL and clinical outcomes among PLHIV.
Keywords: Antiretroviral Therapy; Delivery of Health Care; HIV Infections; Health Services Accessibility; Quality of Life.
Conflict of interest statement
Additional Declarations: No competing interests reported. Competing interests All authors declare no competing interests
Figures
Similar articles
-
Impact of differentiated service delivery models on quality of life among people living with HIV in Uganda- a quasi-experimental study.AIDS Res Ther. 2025 Jun 2;22(1):56. doi: 10.1186/s12981-025-00741-9. AIDS Res Ther. 2025. PMID: 40457424 Free PMC article.
-
Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.PLoS One. 2024 Jan 2;19(1):e0296239. doi: 10.1371/journal.pone.0296239. eCollection 2024. PLoS One. 2024. PMID: 38166009 Free PMC article.
-
Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.J Int AIDS Soc. 2021 Oct;24 Suppl 6(Suppl 6):e25820. doi: 10.1002/jia2.25820. J Int AIDS Soc. 2021. PMID: 34713591 Free PMC article.
-
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.J Int AIDS Soc. 2020 Nov;23(11):e25640. doi: 10.1002/jia2.25640. J Int AIDS Soc. 2020. PMID: 33247517 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
References
-
- Holzemer WL, Human S, Arudo J, Rosa ME, Hamilton MJ, Corless I, Robinson L, Nicholas PK, Wantland DJ, Moezzi S, Willard S. Exploring HIV stigma and quality of life for persons living with HIV infection. J Assoc Nurses AIDS Care. 2009;20(3):161–8. - PubMed
-
- WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2016. - PubMed
-
- IAS. Differentiated care for HIV: a decision framework for antiretroviral therapy delivery. 2016.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources